| Dr Mark W Viner, MD | |
|
145 Isidor Ct, Suite A, Sparks, NV 89441-6304 | |
| (775) 772-6015 | |
| Not Available |
| Full Name | Dr Mark W Viner |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 145 Isidor Ct, Sparks, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790899805 | NPI | - | NPPES |
| 1497080956 | Other | NV | NPI TYPE 2 ORGANIZATIONAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 6983 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark W Viner, MD 145 Isidor Ct, Suite A, Sparks, NV 89441-6304 Ph: (775) 772-6015 | Dr Mark W Viner, MD 145 Isidor Ct, Suite A, Sparks, NV 89441-6304 Ph: (775) 772-6015 |
News Archive
For expectant moms who may contemplate the pros and cons of natural child birth or Caesarian section, a Henry Ford Hospital study suggests that C-section babies are susceptible to developing allergies by age two.
A national survey of recent hospital patients commissioned by TransUnion found that two-thirds of adults nationwide would like to see greater transparency in their hospital bill while only three in 10 of those surveyed were aware they could possibly qualify for charity care programs.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that Genentech Inc., a wholly owned member of the Roche Group, used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue.
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
A radiopharmaceutical for advanced identification of cancer, labeled with the technetium-99 isotope, is ready for the preclinical-phase trial.
› Verified 4 days ago
Dr. Christopher Charles, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 | |
Yixiang Chen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 | |
Usha Kiran Nuthi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2385 E Prater Way, Suite 205, Sparks, NV 89434 Phone: 775-356-4888 Fax: 775-356-4890 | |
Vasudha Ahuja, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 | |
Ira Pauly, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 | |
Dr. Howard Hale Henson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 Galletti Way, Sparks, NV 89431 Phone: 775-688-1900 Fax: 775-688-1962 | |
Dr. Yvette Renee Kaunismaki, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2004 |